Cumberland Partners’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-33,500
| Closed | -$1.42M | – | 179 |
|
|
2021
Q4 | $1.42M | Buy |
33,500
+1,500
| +5% | +$63.7K | 0.1% | 113 |
|
|
2021
Q3 | $1.39M | Sell |
32,000
-5,000
| -14% | -$217K | 0.11% | 114 |
|
|
2021
Q2 | $1.58M | Buy |
37,000
+2,000
| +6% | +$85.5K | 0.12% | 109 |
|
|
2021
Q1 | $1.35M | Buy |
35,000
+10,000
| +40% | +$387K | 0.11% | 112 |
|
|
2020
Q4 | $899K | Buy |
25,000
+2,500
| +11% | +$89.9K | 0.08% | 123 |
|
|
2020
Q3 | $860K | Sell |
22,500
-2,500
| -10% | -$95.6K | 0.09% | 106 |
|
|
2020
Q2 | $878K | Buy |
25,000
+3,000
| +14% | +$105K | 0.09% | 119 |
|
|
2020
Q1 | $718K | Buy |
22,000
+4,350
| +25% | +$142K | 0.09% | 111 |
|
|
2019
Q4 | $798K | Buy |
17,650
+4,150
| +31% | +$188K | 0.07% | 124 |
|
|
2019
Q3 | $549K | Hold |
13,500
| – | – | 0.05% | 127 |
|
|
2019
Q2 | $580K | Buy |
+13,500
| New | +$580K | 0.06% | 131 |
|